New immunotherapy combo shows promise against tough colorectal cancers
Disease control
Recruiting now
This study tests a new immunotherapy drug (STC-1010) combined with standard chemotherapy for people with advanced colorectal cancer that cannot be removed by surgery. The goal is to find a safe dose and see if it helps control the cancer longer. About 90 adults aged 18-75 will pa…
Phase: PHASE1, PHASE2 • Sponsor: Brenus Pharma • Aim: Disease control
Last updated May 17, 2026 09:03 UTC